Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455888 | SCV000538959 | likely benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Silent variant not in splice consensus |
Labcorp Genetics |
RCV000883038 | SCV001026311 | benign | not provided | 2018-12-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000883038 | SCV004155109 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | DNAH6: BP4, BP7 |
Breakthrough Genomics, |
RCV000883038 | SCV005257636 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003970259 | SCV004782509 | likely benign | DNAH6-related disorder | 2019-04-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |